Juridical Analysis of Doctors Engaging in Collusion with Pharmaceutical Companies in Prescription of Medications
DOI:
https://doi.org/10.19166/lp.v2i2.7359Λέξεις-κλειδιά:
Collusion, Doctor, Pharmacy TradeΠερίληψη
In Indonesia, the legal rules that regulate the prohibition of doctors receiving gifts from pharmaceutical companies have not had a significant impact because the existing regulations only exist in the realm of ethics and administration. As a result, the collaboration between doctors and pharmaceutical companies in prescribing drugs continues and has a negative impact on patients. This research analyses the actions of doctors and pharmaceutical companies colluding in prescribing drugs to patients. The purpose of this research is to understand the legal responsibility of doctors and pharmaceutical companies colluding in prescribing drugs to patients, and also to understand the comparison of prevention of collusion between doctors and pharmaceutical companies in drug marketing in Indonesia and the United States. This study uses normative legal research because this research is only intended for written regulations, so this research is closely related to literature because it requires secondary data. The findings of this study indicate that collusion between doctors and pharmaceutical companies, which involves unethical or illegal agreements, can result in civil legal liability. However, if we review the law in the United States, the United States has stronger regulations, better transparency, and stricter legal sanctions in preventing collusion between doctors and pharmaceutical companies in drug marketing compared to Indonesia.
Αναφορές
Law and Regulations:
The 1945 Constitution of the Republic of Indonesia.
Indonesian Civil Code.
Law Number 11 of 1980 on on the Criminal Act of Bribery of Financial/Administrative Rights of Leaders and Members of Highest/High State Institutions and Former Members of High State Institutions as well as Former Leaders of Highest/Higher State Institutions and Former Members of High State Institutions.
Law Number 8 of 1999 on Consumer Protection. State Gazette of the Republic of Indonesia of 1999 Number 22, Supplement to the State Gazette of the Republic of Indonesia Number 3821.
Law Number 31 of 1999 on Eradication of the Criminal Act of Corruption. State Gazette of the Republic of Indonesia of 1999 Number 140, Supplement to the State Gazette of the Republic of Indonesia Number 3874.
Law Number 20 of 2001 on Amendment of Law Number 31 of 1999 on Eradication of the Criminal Act of Corruption. State Gazette of the Republic of Indonesia of 2001 Number 134, Supplement to the State Gazette of the Republic of Indonesia Number 4150.
Law Number 29 of 2004 on Medical Practice. State Gazette of the Republic of Indonesia of 2004 Number 116, Supplement to the State Gazette of the Republic of Indonesia Number 4431.
Law Number 36 of 2009 concerning Health Law. State Gazette of the Republic of Indonesia of 2009 Number 144, Supplement to the State Gazette of the Republic of Indonesia Number 5063.
Regulation of Minister of Health Number 14 of 2014 on Controlling Gratification in the Scope of Ministry of Health.
Regulation of Minister of Health Number 11 of 2017 on Patient’s Safety.
Circular Letter of Minister of Health Number KF/MENKES/167/III/2014 on Drug Procurement Based on the Electronic Catalogue (E-Catalogue).
The Indonesian Medical Code of Ethics of 2012.
Book:
Adji, Indriyanto Seno. Korupsi Kebijakan Aparatur Negara dan Hukum Pidana [Corruption in State Apparatus Policy and Criminal Law]. Jakarta: CV Diadit Media, 2009.
Journal Articles:
Fadhila, Rizka, and Tuti Afriani. “Penerapan Telenursing Dalam Pelayanan Kesehatan: Literature Review [Application of Telenursing in Health Services: Literature Review].” Jurnal Keperawatan Abdurrab 3, no. 2 (2020): 77–84. http://dx.doi.org/10.36341/jka.v3i2.837.
Fadlian, Aryo. “Pertanggungjawaban Pidana Dalam Suatu Kerangka Teoritis [Criminal Responsibility in a Theoretical Framework].” Jurnal Hukum Positum 5, no. 2 (2020): 10–19. https://journal.unsika.ac.id/index.php/positum/article/view/5556.
Fitri Z., Yenny. “Tinjauan Hukum Dokter Yang Berkolusi Dengan Perusahaan Farmasi Dalam Meresepkan Obat [Juridical Analysis of Doctors Colluting with Pharmasical in Pharmaceutical Companies in Prescribing Medications].” Jurnal Cendekia Hukum 3, no. 2 (2018): 272–282. https://doi.org/10.33760/jch.v3i2.31.
Sari, Indah. “Perbuatan Melawan Hukum (PMH) Dalam Hukum Pidana dan Hukum Perdata [Torts in Criminal Law and Civil Law].” Jurnal Ilmiah Hukum Dirgantara 11, no. 1 (2020): 53–70. https://journal.universitassuryadarma.ac.id/index.php/jihd/article/view/651.
Scientific Papers:
Adilah, Anis Afkar, Amelia Rizki Ningtiyas, Restiana Nugraheni Kusumastuti, Ilham Taufik Mandja, Khonsa Afifah Husniyyah, Nuzhulla Nuri Akmalina, and S Sulistyani. “Kerjasama Dokter dan Industri Farmasi Terkait Obat Pada Pasien [Cooperation between Doctors and Pharmaceutical Traders Related to the Provision of Drugs to Patients].” Proceeding Book Call for Papers Fakultas Kedokteran Universitas Muhammadiyah Surakarta (Thalamus), 2021.
Internet:
Tarigan, Mitra. “Gratifikasi Dokter, Menteri Nila Akan Temui Farmasi dan IDI.” Tempo, accessed June 26, 2023. https://nasional.tempo.co/read/717860/gratifikasi-dokter-menteri-nila-akan-temui-farmasi-dan-idi.
Sinaga, Eri Komar. “Menteri Kesehatan Gandeng KPK Atur Gratifikasi Dokter.” Tribun News, November 6, 2015. https://www.tribunnews.com/nasional/2015/11/06/menteri-kesehatan-gandeng-kpk-atur-gratifikasi-dokter.
Syarifah, Fitri. “Kemenkes Gandeng KPK Cegah Gratifikasi dan Korupsi.” Liputan 6, April 2, 2014. https://www.liputan6.com/health/read/2031172/kemenkes-gandeng-kpk-cegah-gratifikasi-dan-korupsi.
Wathoni, Nasrul. “Lingkaran Terlarang Perusahaan Farmasi – MedRep – Praktisi Kesehatan dalam Dunia Distribusi Obat.” Kompasiana, November 24, 2014. https://www.kompasiana.com/nasrulwathoni/54f9368ea3331169018b4a3e/lingkaran-terlarang-perusahaan-farmasi-medrep-praktisi-kesehatan-dalam-dunia-distribusi-obat.
Λήψεις
Δημοσιευμένα
Τεύχος
Ενότητα
Άδεια
Πνευματική ιδιοκτησία (c) 2024 Amanda Regina Pallas Heriman, Caroline, Clarisa Permata Hasian, Ega Yolanda Lumban Tobing, Johan Alexander, Novia Naibaho
Αυτή η εργασία είναι αδειοδοτημένη υπό το Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
